# CHV Capital

> CHV Capital is a VC fund backing Health Care and Biotechnology. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Indianapolis, United States
- Total investments: 15
- Last investment: Sep 2015
- Lead investor: 13%
- Last fund: Jan 2008
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/iu_health
- Website: http://www.chvcapital.com
- Facebook: https://www.facebook.com/iuhealth

CHV Capital is a VC fund in Indianapolis focused on Health Care and Biotechnology. CHV Capital, Inc. (CHV) is an early-stage investor focused on building value in business opportunities that serve a business or clinical need in the market. They are a return-driven venture capital fund guided by the strategic objectives of Indiana University Health, Indiana’s largest health care system.

## Contacts

5 contacts available for CHV Capital. Shizune tracks 2 team members at CHV Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/chv-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 53% |
| Biotechnology | 5 | 33% |
| Medical Device | 5 | 33% |
| Medical | 4 | 27% |
| Mobile | 1 | 7% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series D | 4 | 27% |
| Series C | 3 | 20% |
| Funding Round | 3 | 20% |
| Series A | 2 | 13% |
| Series B | 2 | 13% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Charles Schalliol | Director | 0 | https://shizune.co/investors/profile/charles-schalliol |
| Kyle Salyers | Co-Founder and Managing Director | 4 | https://shizune.co/investors/profile/kyle-salyers |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PerfectServe | PerfectServe, Inc. provides physician contact and patient care communication services to hospitals, physician practices and other healthcare clients in more than 130 markets across the U.S.Since 2000, the company has experienced compound annual growth in excess of 50 percent, demonstrating the market demand for our innovative physician contactofferings, PerfectServe One-2-Oneâ„¢ and PerfectServe OnCall.â„¢Independent research has found that the PerfectServe platform is able to provide medical professionals with unprecedented accuracy, reliability and personal control over physician contact processes.At present, PerfectServe facilitates tens of thousands of interactions per day between our hospital and physician clients and their approximately 12 million patients. | $21M | Series D | Sep 30, 2015 |  |
| NeoChord | NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation.In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chestincision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass.Founded in 2007 and is based in St. Louis Park, MN. | $20M | Series C | Jun 09, 2015 |  |
| Health Catalyst | Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical. | $70M | Series D | Mar 17, 2015 |  |
| Par8o | The current healthcare crisis is a uniquely American challenge and ultimately will be solved with a uniquely American solution. The most simple of solutions has yet to be attempted. We believe healthcare is best managed by direct collaboration between patients and the physicians providing their care. | $10.5M | Series A | Jan 08, 2015 |  |
| Health Catalyst | Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical. | $41M | Series C | Jan 27, 2014 |  |
| Par8o | The current healthcare crisis is a uniquely American challenge and ultimately will be solved with a uniquely American solution. The most simple of solutions has yet to be attempted. We believe healthcare is best managed by direct collaboration between patients and the physicians providing their care. |  | Seed | Oct 03, 2013 |  |
| Health Catalyst | Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical. | $8M | Series B | Mar 01, 2013 |  |
| Mindframe | MindFrame, Inc. develops solutions for treating patients suffering from ischemic stroke. It offers MindFrame Capture LP device that delivers rapid flow restoration and clot extraction to help clinicians provide improved clinical outcomes for their patients. The company also provides MINDFRAME CAPTURE for ICA-T and basilar arteries, and MCAterritory. In addition, it offers MINDFRAME FLOW that creates a bypass for faster flow restoration for transmitting plasminogen activators and plasminogen to thrombus. MindFrame, Inc. was founded in 2007 and is based in Irvine, California. As of July 2, 2012, MindFrame, Inc. operates as a subsidiary of Covidien plc. | $6.5M | Series C | May 18, 2012 |  |
| iScience Interventional | iScience Interventionalâ„¢ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies.This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eyeto aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. | $2.8M |  | Jan 27, 2012 |  |
| MedVentive | MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients.Founded in 1997 by physicians, MedVentive has been at the forefront of the development ofinnovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality. | $12M | Series D | Oct 21, 2011 |  |

10 of 15 investments shown.

## Co-investors
- [Kaiser Permanente Ventures](https://shizune.co/investors/profile/kaiser-permanente-ventures) — VC Fund, 3 deals together
- [Ascension Ventures](https://shizune.co/investors/profile/ascension-ventures) — VC Fund, 2 deals together
- [Norwest](https://shizune.co/investors/profile/norwest-venture-partners) — VC Fund, 2 deals together
- [RC Capital](https://shizune.co/investors/profile/river-cities-capital) — VC Fund, 2 deals together
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund, 2 deals together
- [Sorenson Capital](https://shizune.co/investors/profile/sorenson-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does CHV Capital invest in?

CHV Capital invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series D and Series C stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact CHV Capital?

Public channels for CHV Capital include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CHV Capital?

The team at CHV Capital includes Charles Schalliol (Director) and Kyle Salyers (Co-Founder and Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co